Iran Unveils Anti-Coronavirus Medicine Dubbed Saliravira
TEHRAN (FNA)- The four-dimensional drug, 'Saliravira', which has been produced by an Iranian knowledge-based company, was unveiled with the permission of the Food and Drug Administration of Iran on Monday.
The biotechnology headquarters of the Vice Presidency for Science and Technology of Iran defined the plan to make an inhaler and preventive Corona drug and reduce COVID-19 complications in cooperation with a knowledge-based Company located in Pardis Technology Park to operationalize it.
The four-dimensional drug consists of nasal and oral sprays with the aim of eliminating viruses located in these areas, antiseptic pills and antivirals to eliminate blood viruses, and incense drops to reduce pulmonary complications.
The Saliravira drug has passed clinical tests at Shahid Beheshti University of Medical Sciences and Imam Khomeini Hospital and has received a license from the Food and Drug Administration.
This drug is completely herbal and native to Iran and has no side effects.
In terms of drug form, Saliravira is a new drug and is produced in four medicinal forms including tablets, nasal spray, oral spray, and inhaler drops.